← All organizations
Highest phase reached
Phase 4
Acquired by Aptalis → Forest Laboratories → Actavis → Allergan PLC (2015) → AbbVie on Jan 1, 2011
Timeline
Drugs by trial phase (14 distinct, 11 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (12 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Approved for
Studied for
- Adenoma
- Adenomatous Polyposis Coli
- Colorectal Neoplasms
- Diarrhea
- Exocrine Pancreatic Insufficiency
- Fatty Liver
- Fibrosis
- Helicobacter Infections
- Infections
- Inflammation
- Irritable Bowel Syndrome
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Nasopharyngeal Neoplasms
- Non-alcoholic Fatty Liver Disease
- Pancreatitis
- Pancreatitis, Chronic
- Proctitis
- Syndrome
- Ulcer
- Urinary Bladder Neoplasms
Marketed drugs (2)
Recent trials (12)
- NCT01430234CollaboratorPhase 4Oct 1, 2011
- NCT01358708Study directorPhase 3Jun 1, 2010
- NCT01016262Study directorPhase 3Sep 1, 2009
- NCT01016262Lead sponsorPhase 3Sep 1, 2009
- NCT00712413Study directorPhase 3Aug 1, 2008
- NCT00669955Study directorPhase 3Jun 1, 2008
- NCT00559052Lead sponsorPhase 2Mar 1, 2008
- NCT00308399CollaboratorPhase 2/Phase 3Nov 1, 2005
- NCT00470171Lead sponsorPhase 2Oct 1, 2005
- NCT00322699CollaboratorPhase 1/Phase 2Feb 1, 2005
- NCT00134758CollaboratorPhase 2/Phase 3Oct 1, 2004
- NCT00490620CollaboratorPhase 2/Phase 3Jan 1, 2004
Details
- Founded
- Birmingham, AL, US Jan 1, 1991
- Last known activity
- Oct 1, 2011